Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow

• Published in: Molecular genetics and metabolism 2003-08, Vol.79 (4), p.233-244
• Main Authors: Zheng, Yi, Rozengurt, Nora, Ryazantsev, Sergey, Kohn, Donald B, Satake, Noriko, Neufeld, Elizabeth F
• Format: Article
• Language: English
• Subjects: Animals; Bone marrow transplantation; Bone Marrow Transplantation - physiology; Brain - enzymology; Female; Gene therapy; Genetic Therapy; Genetic Vectors; Glycosaminoglycan; Hurler; Iduronidase - genetics; Iduronidase - metabolism; Kidney - enzymology; Liver - enzymology; Lysosome; Male; Mice; Mice, Knockout; Mouse model; Mucopolysaccharidosis; Mucopolysaccharidosis I - therapy; Retroviral vector; Retroviridae - genetics; Spleen - enzymology; Transduction, Genetic; α- l-Iduronidase
• ISSN: 1096-7192; 1096-7206
• DOI: 10.1016/S1096-7192(03)00116-1

Mucopolysaccharidosis I is a lysosomal storage disorder caused by mutations in the IDUA gene, resulting in deficiency of α- l-iduronidase and accumulation of glycosaminoglycans. Bone marrow transplantation has been the only available therapy, soon to be joined by enzyme replacement. We have tested retroviral gene therapy in a knockout mouse model of the disease. Bone marrow from Idua−/− male donor mice was transduced with human IDUA cDNA in an MND vector and transplanted into 6–8-week-old, lethally irradiated female Idua−/− mice. Sham-treated mice received Idua−/− bone marrow that was either unmodified or transduced with eGFP. Unmodified Idua+/+ (wild type) bone marrow was transplanted for comparison. Recipient mice were sacrificed 2–6 months after transplantation. Three biochemical parameters were used to gauge therapeutic success: appearance of α- l-iduronidase activity, reduction of β-hexosaminidase activity and reduction of soluble glycosaminoglycan accumulation. Transplantation of unmodified +/+ bone marrow was effective in reducing storage in liver and spleen, but not in kidney or brain. The level of α- l-iduronidase activity achieved by transplantation of IDUA-transduced bone marrow varied greatly between experiments. But even modest activity resulted in correction of pathology of kidney, bladder epithelium, fibrocartilage, choroid plexus, and thalamus, as seen by light microscopy, while electron microscopy showed the presence of some normal neurons in the cortex. The partial correction of brain pathology is attributed to migration of donor hematopoietic cells, demonstrated by the presence of the Y chromosome and of normal microglia in the brain of mice receiving IDUA cDNA.